PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News   May 21, 2018 | Original story from PhoreMost

 
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

Dr Chris Torrance, CEO at PhoreMost Ltd.

 
 
 

RELATED ARTICLES

Penn Medicine Biochemist Receives Major Award for Research on Epigenetic Protein Modifications via Mass Spec

News

Benjamin A.Garcia, PhD, an expert in quantitative proteomics and Presidential Professor of Biochemistry and Biophysics in the Perelman School of Medicine at the University of Pennsylvania, has been awarded the Biemann Medal by the American Society for Mass Spectrometry (ASMS). The early-career award recognizes significant achievement in basic or applied mass spectrometry.

READ MORE

Psychedelics and the Potential of Plant Medicine

News

Hallucinogenic drugs are having a moment. A series of recent studies suggests that psychedelics may be useful for alleviating depression and anxiety, PTSD, and addiction.

READ MORE

New Speakers from Roche and Imperial College London Announced for SMi’s ADMET Event

News

SMi Group Reports: With less than 4 weeks left until the 13th annual ADMET Conference commences in London, SMi announces two new speakers joining the event.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy